SCHEMBL28800057

SCHEMBL28800057

C=CC(c1ccc(C(C)C)cc1)S(=O)(=O)n1c(C(O)c2cccc(C(=O)O)c2)cc2cc(Cl)ccc21

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ACLY P53396 6/20 0.43
▸ CCR2 P41597 1/20 0.38
▸ PHGDH O43175 3/20 0.38
▸ CA1 P00915 1/20 0.37
▸ CA2 P00918 1/20 0.37
▸ CA9 Q16790 1/20 0.37
▸ PSEN1 P49768 1/20 0.35
▸ PSEN2 P49810 1/20 0.35
▸ APH1B Q8WW43 1/20 0.35
▸ NCSTN Q92542 1/20 0.35
▸ APH1A Q96BI3 1/20 0.35
▸ PSENEN Q9NZ42 1/20 0.35
▸ PTGER4 P35408 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.34
▸ MRGPRX4 Q96LA9 1/20 0.34
▸ PPARG P37231 2/20 0.33
▸ PPARD Q03181 2/20 0.33
▸ PPARA Q07869 2/20 0.33
▸ ADRB2 P07550 1/20 0.33
▸ ADRB1 P08588 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12096936 0.85 ACLY (0.52) ACLYCCR2PHGDHCA1CA2
SCHEMBL27867732 0.83 CCR2 (0.45) ACLYCCR2PHGDHMRGPRX4PPARG
SCHEMBL27713457 0.83 PSEN1 (0.46) ACLYPHGDHPSEN1PSEN2APH1B
SCHEMBL28775103 0.81 MEN1 (0.41) ACLYPHGDHPSEN1PSEN2APH1B
SCHEMBL28800056 0.80 ACLY (0.41) ACLYCCR2PHGDHCA1CA2
SCHEMBL27733784 0.80 PSEN1 (0.42) ACLYPHGDHPSEN1PSEN2APH1B
SCHEMBL27733852 0.79 PSEN1 (0.39) ACLYPHGDHPSEN1PSEN2APH1B
SCHEMBL27833766 0.78 PHGDH (0.38) ACLYPHGDHPSEN1PSEN2APH1B
SCHEMBL28797216 0.78 PHGDH (0.41) ACLYPHGDHPSEN1PSEN2APH1B
SCHEMBL28770821 0.77 PTGS2 (0.39) ACLYPHGDHPSEN1PSEN2APH1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102596906-A Use of indole derivatives as NURR-1 activators as agents for the treatment of Parkinson's disease FOURNIER LAB SA 2012-07-18 — — CN disclosed
Send feedback